Clinical Science · AI Governance · Consumer Health

Olga Lavinda, PhD

Biomedical scientist building evidence-based health intelligence. From molecular pharmacology to deployed AI, with published methodology at every layer.

NIH Kirschstein NRSA Fellow · National Institutes of Health
Eugene M. Farber Award · Society for Investigative Dermatology
CEO, Health AI LLC · Published Author · Research Faculty
ORCID Scholar LinkedIn Health AI GitHub
Olga Lavinda, PhD
16
Publications
6
Awards
2x
NIH Fellow
8
Domains
50+
Countries

"I turn clinical evidence into health products people can use. Then I publish the methodology so you can verify it."

Expertise

Areas of deep expertise.

AI Validation & Governance

RIGOR framework. FDA digital health readiness. EU AI Act. Post-deployment monitoring. Clinical AI evidence architecture.

Ingredient Safety Intelligence

Multi-dimensional safety databases. Evidence tiers. Published methodology with DOIs. API design. Consumer product safety at scale.

Computational Biochemistry

AlphaFold modeling. Molecular docking. In silico mutagenesis. Polypharmacology. Chemometrics and analytical validation.

Histamine & Inflammatory Pathways

hDAO enzyme modeling. Mast cell activation. Dietary trigger mapping. HS and rosacea connection. DAO deficiency prevalence.

Dermatology & Skincare Science

Tyrosinase-TYRP1-TYRP2 melanogenic complex. Pregnancy and breastfeeding skincare safety. OCA genotype-phenotype.

DTC Health & Telehealth

Consumer health product design. Evidence-based telehealth. LDN in dermatology. Regulatory-compliant marketing.

Maternal & Pediatric Health

Lactation pharmacology. CMPA cross-reactivity. Infant formula analysis. Postpartum safety. 18 formulas, 15 dimensions.

AI Literacy & Education

Prompt Ladder methodology. IRB-filed study. Faculty workshop design. ACS CHED 2026.

Health AI was selected over Amazon, Microsoft, IBM, SAS, NTT Data, Dell, and Oracle for a major enterprise AI governance engagement.

Research

Published author and speaker.

Clarity Ingredient Safety Engine: API & Data Dictionary
1,500+ validated ingredients, 15 safety dimensions, evidence tier system.
DOI: 10.5281/zenodo.19423468
Beta-Glucan as a Galactagogue: A Critical Review
Systematic review of galactagogue claims vs clinical evidence.
DOI: 10.5281/zenodo.19389747
CMPA Formula Comparative Analysis
18 infant formulas, 15 dimensions. Six compounding factors identified.
DOI: 10.5281/zenodo.19391415
Earlier work: tyrosinase-TYRP1-TYRP2 melanogenic complex, GCN2 kinase inhibitors, indigo and Tyrian purple crystallography.
Full publication list →
Products

Research. Deployed.

Clarity Safety Engine
Ingredient safety infrastructure. 1,500+ validated ingredients. API-enabled. Deployed globally.
View system →
RIGOR System
Clinical AI validation system. FDA-to-CMS evidence bridge. Enterprise deployed.
View system →
DTC Telehealth
Evidence-based dermatology platform. Trigger tracking powered by Clarity.
Learn more →
Affiliations
Coalition for Health AI (CHAI) American Chemical Society Women in AI Society for Investigative Dermatology

Initiate a Strategic Partnership.

Strategic advisory · Clinical AI validation · Evidence architecture · Research collaboration · Partnerships.

Start a Partnership
Typical response: within 24 hours

© 2026 Olga Lavinda · Health AI LLC